These drugs can be effective in reversing such hearing loss, although at the cost of side-effects. Prompted by such observations, we implemented a protocol using sodium enoxaparin associated with a venovenous hemofiltration for treatment of IMSNHL. Methods: Hemofiltration was performed at the first ...
Responses were present at 3 months in 4 children; 3 of the 4 had normal hearing and 1 a loss at 4 kHz only. All 10 children who still had absent ABR at 3 months had SNHL; 9 of the 10 required active treatment. We conclude that neonatal ABR accurately identify very preterm infants ...
Sensorineural hearing loss (SNHL) is a common disability in the world; however, at present, options for the pharmacological treatment of SNHL are very limi... Nakagawa,Takayuki - 《Frontiers in Pharmacology》 被引量: 13发表: 2014年 Neuroblastoma stage Iv-S A review of stage IV-S neuroblasto...
or systemic medications to treat noise-induced hearing loss (NIHL). This invention differs from mechanical noise attenuators or hearing protection devices in that it does not need to be worn and does not decrease hearing acuity as hearing protectors do. Also, this treatment has the potential to ...
Introduction Sensorineural hearing loss (SNHL) results from congenital or acquired conditions affecting structures from the inner-hair cells of the cochlea to retrocochlear nerve tissue. Cochlear implantation (CI) is the most definitive treatment for patients with bilateral severe-to-profound SNHL. The...